Results 41 to 50 of about 329,096 (211)

Stereotactic ablative radiotherapy in the UK: current status and developments [PDF]

open access: yesThe British Journal of Radiology, 2013
Stereotactic ablative radiotherapy (SABR) has developed from the principles and techniques used in the stereotactic radiosurgery treatment of brain metastases. Advances in computer technology, imaging, planning and treatment delivery and evidence from retrospective analysis of single- and multi-institutional early-phase studies have established SABR in
P, Jain   +5 more
openaire   +2 more sources

Stereotactic ablative radiotherapy for oligometastatic breast cancer in elderly patients

open access: yes, 2020
Breast cancer (BC) is the principal cause of cancer-related death in women. Metastatic patients are usually treated with a systemic therapy, but clinical results are limited.
Lloret, Marta   +10 more
core   +1 more source

Concurrent Stereotactic Ablative Radiotherapy and Antiangiogenic Targeted Agents: Redefining the Therapeutic Strategy

open access: yes, 2023
If, on one hand, the prognosis for patients with metastatic renal cell carcinoma (mRCC) has greatly improved with immune-based combinations, on the other hand their effectiveness could theoretically lead to a decrease in the use of locoregional ...
Porta, Camillo   +3 more
core   +1 more source

Expert Strategies: Controversies in Management of Sinonasal Malignancies—Global Perspectives Through a Mixed Methods Approach

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Sinonasal malignancies (SNMs) are a rare group of diseases with limited high‐level evidence to guide management. Where data are currently lacking, contemporary management principles may be guided by clinical expertise and experience.
Garret Choby   +56 more
wiley   +1 more source

Feasibility of split-course stereotactic ablative radiotherapy for oligometastases [PDF]

open access: yesJapanese Journal of Clinical Oncology, 2018
There is growing interest in the use of stereotactic ablative radiotherapy (SABR) for oligometastases. However, extreme caution should be exercised in treating tumors closely located to organs at risk (OARs) with SABR. To reduce complications, we have applied split-course SABR to oligometastases closely located to OARs or to those being retreated with ...
Paik, Eun Kyung   +6 more
openaire   +2 more sources

Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy

open access: yes, 2020
Stereotactic body radiotherapy (SBRT) or stereotactic ablative radiotherapy (SABR) has been shown to increase survival rates in oligometastatic disease (OMD), but local control of colorectal metastases remains poor. We aimed to explore the natural course
Rigo, Michele   +11 more
core   +1 more source

A decision tool for radiographer-led abdominal image-guided stereotactic ablative body radiotherapy – Experience from a single institution

open access: yesTechnical Innovations & Patient Support in Radiation Oncology, 2021
A decision tool for radiographer-led image-guided radiotherapy (IGRT) using cone-beam CT (CBCT) for abdominal stereotactic radiotherapy was developed and successfully implemented in a single department.
Mairead Daly   +5 more
doaj   +1 more source

Stereotactic Body Radiation Therapy for Head and Neck Cancers With Perineural Spread

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Perineural spread (PNS) in head and neck cancer (HNC) is technically challenging due to complex target volumes adjacent to critical organs. Data on stereotactic body radiation therapy (SBRT) for PNS is scarce. Methods This retrospective study included patients treated with SBRT for PNS across two centers in the USA and Canada from ...
Anna K. Lawless   +21 more
wiley   +1 more source

Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer [PDF]

open access: yesThe British Journal of Radiology, 2017
The metastatic state of most solid cancers traditionally has been regarded as an incurable dissemination of disease, with treatment focused on delaying progression rather than eliminating all tumour burden. In this setting, local therapies including surgery and radiotherapy are directed at quality of life end points and not at improvement in survival ...
Neil B, Desai   +2 more
openaire   +2 more sources

Prostate stereotactic ablative body radiotherapy using a standard linear accelerator:Toxicity, biochemical, and pathological outcomes

open access: yes, 2013
Biological dose escalation through stereotactic ablative radiotherapy (SABR) holds promise of improved patient convenience, system capacity and tumor control with decreased cost and side effects.
Zhang, Liying   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy